Cargando…

The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey

OBJECTIVE: We aimed to compare laboratory features, histopathological types, response to treatment of patients with non hodgkin lymphoma in our department and other regions. METHODS: A total of 80 patients nonhodgkin lymphoma were evaluated. Because we had only 80 patients with complete data, we use...

Descripción completa

Detalles Bibliográficos
Autores principales: Yildirim, Rahsan, Sincan, Gulden
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408640/
https://www.ncbi.nlm.nih.gov/pubmed/30881401
http://dx.doi.org/10.12669/pjms.35.1.415
_version_ 1783401808295624704
author Yildirim, Rahsan
Sincan, Gulden
author_facet Yildirim, Rahsan
Sincan, Gulden
author_sort Yildirim, Rahsan
collection PubMed
description OBJECTIVE: We aimed to compare laboratory features, histopathological types, response to treatment of patients with non hodgkin lymphoma in our department and other regions. METHODS: A total of 80 patients nonhodgkin lymphoma were evaluated. Because we had only 80 patients with complete data, we used T test for comparison of groups. We evaluated the parameters affecting surveillance with cox regression analysis. RESULTS: The most common histological types of nonhodgkins lymphoma was diffuse large b cell lymphoma (n: 63, 78.75%). Thirty-nine percent of all patients had anemia, 32% had hypoalbunemia, 71.25% had elevated serum LDH, 32.5% had elevated serum ß2 microglobulin value. Advanced age, the presence of bulky disease, elevated Ki-67 level, IPI score, refractory to first line treatment were found to be correlated with shorter survival time. We treated 77 (96.25%) patients with doxorubicin containing regimen. Complete and partial remission rates of first line treatment were 77.5% and 10%, respectively. Seven (8.75%) patients died because of disease progression and 1 (1.25%) patient died due to sepsis. CONCLUSION: The frequency of lymphoma subtypes, clinical characteristics, treatment outcomes and survival rate vary from region to region. Therefore it is important to determine dissimilarity of these parameters for improve of survey.
format Online
Article
Text
id pubmed-6408640
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Professional Medical Publications
record_format MEDLINE/PubMed
spelling pubmed-64086402019-03-15 The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey Yildirim, Rahsan Sincan, Gulden Pak J Med Sci Original Article OBJECTIVE: We aimed to compare laboratory features, histopathological types, response to treatment of patients with non hodgkin lymphoma in our department and other regions. METHODS: A total of 80 patients nonhodgkin lymphoma were evaluated. Because we had only 80 patients with complete data, we used T test for comparison of groups. We evaluated the parameters affecting surveillance with cox regression analysis. RESULTS: The most common histological types of nonhodgkins lymphoma was diffuse large b cell lymphoma (n: 63, 78.75%). Thirty-nine percent of all patients had anemia, 32% had hypoalbunemia, 71.25% had elevated serum LDH, 32.5% had elevated serum ß2 microglobulin value. Advanced age, the presence of bulky disease, elevated Ki-67 level, IPI score, refractory to first line treatment were found to be correlated with shorter survival time. We treated 77 (96.25%) patients with doxorubicin containing regimen. Complete and partial remission rates of first line treatment were 77.5% and 10%, respectively. Seven (8.75%) patients died because of disease progression and 1 (1.25%) patient died due to sepsis. CONCLUSION: The frequency of lymphoma subtypes, clinical characteristics, treatment outcomes and survival rate vary from region to region. Therefore it is important to determine dissimilarity of these parameters for improve of survey. Professional Medical Publications 2019 /pmc/articles/PMC6408640/ /pubmed/30881401 http://dx.doi.org/10.12669/pjms.35.1.415 Text en Copyright: © Pakistan Journal of Medical Sciences http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Yildirim, Rahsan
Sincan, Gulden
The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey
title The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey
title_full The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey
title_fullStr The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey
title_full_unstemmed The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey
title_short The clinicopathologic features and response to treatment of patients with Nonhodgkin Lymphoma: A single-center experiment in Turkey
title_sort clinicopathologic features and response to treatment of patients with nonhodgkin lymphoma: a single-center experiment in turkey
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408640/
https://www.ncbi.nlm.nih.gov/pubmed/30881401
http://dx.doi.org/10.12669/pjms.35.1.415
work_keys_str_mv AT yildirimrahsan theclinicopathologicfeaturesandresponsetotreatmentofpatientswithnonhodgkinlymphomaasinglecenterexperimentinturkey
AT sincangulden theclinicopathologicfeaturesandresponsetotreatmentofpatientswithnonhodgkinlymphomaasinglecenterexperimentinturkey
AT yildirimrahsan clinicopathologicfeaturesandresponsetotreatmentofpatientswithnonhodgkinlymphomaasinglecenterexperimentinturkey
AT sincangulden clinicopathologicfeaturesandresponsetotreatmentofpatientswithnonhodgkinlymphomaasinglecenterexperimentinturkey